HEILONGJIANG ZBD PHARMACEUTICAL CO., LTD.

News Heilongjiang ZBD Pharmaceutical Co., Ltd.

Equities

603567

CNE100002219

End-of-day quote Shanghai S.E. Other stock markets 18:00:00 2024-05-19 EDT			5-day change	1st Jan Change
13 ^CNY	+1.72%		+6.91%	+6.91%

05-07	China Grants Drug Registration Approval for ZBD Pharma's Anti-Epilepsy Injectable	MT
04-29	Heilongjiang ZBD Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

China Grants Drug Registration Approval for ZBD Pharma's Anti-Epilepsy Injectable	05-07	MT
Heilongjiang ZBD Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-29	CI
Heilongjiang ZBD Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	04-29	CI
ZBD Pharma Gets Nod for Tofacitinib Citrate Tablets	02-20	MT
Heilongjiang ZBD Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-27	CI
HeiLongJiang ZBD Pharma Registers Osteoarthritis Drug	23-09-26	MT
Heilongjiang ZBD Pharmaceutical Co., Ltd.(XSSC:603567) added to S&P Global BMI Index	23-09-18	CI
Heilongjiang ZBD Pharmaceutical Co., Ltd.(XSSC:603567) added to FTSE All-World Index	23-09-18	CI
Heilongjiang ZBD Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-23	CI
Tranche Update on Heilongjiang ZBD Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on June 10, 2022.	23-05-10	CI
Heilongjiang ZBD Pharmaceutical Co., Ltd.'s Equity Buyback announced on June 10, 2022 has closed with 2,560,300 shares, representing 0.27% for CNY 30 million.	23-05-09	CI
Heilongjiang ZBD Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-28	CI
Heilongjiang ZBD Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-28	CI
Tranche Update on Heilongjiang ZBD Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on June 10, 2022.	23-04-04	CI
Tranche Update on Heilongjiang ZBD Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on June 10, 2022.	23-01-03	CI
Heilongjiang ZBD Pharmaceutical to Tie Up With Kangyue Technology on Medicine Supplies	22-12-06	MT
Heilongjiang ZBD Gets Approval for Traditional Medicine Product	22-11-04	MT
Heilongjiang ZBD’s Anti-Pulmonary Fibrosis Drug Gets U.S. Patent	22-11-02	MT
Heilongjiang ZBD Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-27	CI
Tranche Update on Heilongjiang ZBD Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on June 10, 2022.	22-10-10	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Heilongjiang ZBD Pharmaceutical Co., Ltd.

Equities

603567

CNE100002219

Summary

Filters